Armata Pharmaceuticals Statistics
Total Valuation
ARMP has a market cap or net worth of $92.39 million. The enterprise value is $232.01 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARMP has 36.23 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 36.23M |
| Shares Outstanding | 36.23M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | -39.15% |
| Owned by Insiders (%) | 0.77% |
| Owned by Institutions (%) | 2.03% |
| Float | 10.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.44 |
| Forward PS | 31.23 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 33.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -23.35% |
| Return on Invested Capital (ROIC) | -25.31% |
| Return on Capital Employed (ROCE) | 89.91% |
| Revenue Per Employee | $114,467 |
| Profits Per Employee | -$428,450 |
| Employee Count | 60 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.67% in the last 52 weeks. The beta is 1.00, so ARMP's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +3.67% |
| 50-Day Moving Average | 2.35 |
| 200-Day Moving Average | 2.00 |
| Relative Strength Index (RSI) | 53.05 |
| Average Volume (20 Days) | 9,353 |
Short Selling Information
The latest short interest is 49,502, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 49,502 |
| Short Previous Month | 67,235 |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.46% |
| Short Ratio (days to cover) | 4.21 |
Income Statement
In the last 12 months, ARMP had revenue of $6.87 million and -$25.71 million in losses. Loss per share was -$1.35.
| Revenue | 6.87M |
| Gross Profit | -27.67M |
| Operating Income | -35.33M |
| Pretax Income | -79.58M |
| Net Income | -25.71M |
| EBITDA | -33.89M |
| EBIT | -35.33M |
| Loss Per Share | -$1.35 |
Full Income StatementBalance Sheet
The company has $4.33 million in cash and $143.96 million in debt, giving a net cash position of -$139.63 million or -$3.85 per share.
| Cash & Cash Equivalents | 4.33M |
| Total Debt | 143.96M |
| Net Cash | -139.63M |
| Net Cash Per Share | -$3.85 |
| Equity (Book Value) | -69.50M |
| Book Value Per Share | -1.92 |
| Working Capital | -112.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$31.58 million and capital expenditures -$511,000, giving a free cash flow of -$32.09 million.
| Operating Cash Flow | -31.58M |
| Capital Expenditures | -511,000 |
| Free Cash Flow | -32.09M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -514.40% |
| Pretax Margin | -374.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARMP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | -0.19% |
| Earnings Yield | -27.83% |
| FCF Yield | -34.74% |
Analyst Forecast
The average price target for ARMP is $9.00, which is 252.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 252.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARMP has an Altman Z-Score of -8.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.8 |
| Piotroski F-Score | 1 |
